Research ArticleHEALTH AND MEDICINE

A mutation-independent CRISPR-Cas9–mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency

See allHide authors and affiliations

Science Advances  12 Feb 2020:
Vol. 6, no. 7, eaax5701
DOI: 10.1126/sciadv.aax5701
PDF Container

Stay Connected to Science Advances

Navigate This Article